找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiopharmaceutical Therapy; Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex

[復(fù)制鏈接]
查看: 46888|回復(fù): 61
樓主
發(fā)表于 2025-3-21 16:15:02 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Radiopharmaceutical Therapy
編輯Lisa Bodei,Jason S. Lewis,Brian M. Zeglis
視頻videohttp://file.papertrans.cn/821/820888/820888.mp4
概述First book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
圖書(shū)封面Titlebook: Radiopharmaceutical Therapy;  Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex
描述.This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It?is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird’s-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence,?.in vivo?.pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics..This book is the first of its kind andis useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology..
出版日期Book 2023
關(guān)鍵詞radiotherapy; cancer therapy; endoradiotherapy; radiopharmaceutical chemistry; Radiotherapeutics; Radioim
版次1
doihttps://doi.org/10.1007/978-3-031-39005-0
isbn_softcover978-3-031-39772-1
isbn_ebook978-3-031-39005-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱(chēng)Radiopharmaceutical Therapy影響因子(影響力)




書(shū)目名稱(chēng)Radiopharmaceutical Therapy影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Radiopharmaceutical Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy被引頻次




書(shū)目名稱(chēng)Radiopharmaceutical Therapy被引頻次學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy年度引用




書(shū)目名稱(chēng)Radiopharmaceutical Therapy年度引用學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy讀者反饋




書(shū)目名稱(chēng)Radiopharmaceutical Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:31:39 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:50:12 | 只看該作者
978-3-031-39772-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
地板
發(fā)表于 2025-3-22 04:52:31 | 只看該作者
Lisa Bodei,Jason S. Lewis,Brian M. ZeglisFirst book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
5#
發(fā)表于 2025-3-22 09:07:33 | 只看該作者
The Production of Therapeutic Radionuclidesh the decay of long-lived radionuclides such as .U, .Th, and .U, upon which chemically distinct daughters can be separated for incorporation into radiopharmaceuticals. The rate of the production of a given radionuclide depends on the cross section of the nuclear reaction on the target material, the
6#
發(fā)表于 2025-3-22 13:41:48 | 只看該作者
7#
發(fā)表于 2025-3-22 17:46:55 | 只看該作者
8#
發(fā)表于 2025-3-23 00:06:59 | 只看該作者
9#
發(fā)表于 2025-3-23 05:23:38 | 只看該作者
Case Study #3: Antibody Fragments in Radiopharmaceutical Therapylity, unfavorable tissue distribution, and reduced binding affinity of radiolabeled antibody fragments have inhibited their widespread application in radiopharmaceutical therapy. In response, a great deal of effort has been dedicated to optimize the pharmacokinetics of antibody fragments (especially
10#
發(fā)表于 2025-3-23 06:38:13 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-18 05:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
普格县| 乾安县| 秭归县| 尖扎县| 紫阳县| 兴业县| 凤冈县| 临沂市| 昌乐县| 苍梧县| 荔波县| 龙海市| 米脂县| 崇义县| 科技| 屯昌县| 开远市| 金平| 刚察县| 万安县| 巴楚县| 灌云县| 永城市| 海门市| 怀集县| 渝北区| 招远市| 广昌县| 临江市| 池州市| 嘉兴市| 仁怀市| 琼中| 吉木萨尔县| 阳朔县| 嵊泗县| 洞头县| 三穗县| 静安区| 镇安县| 三河市|